Nedd9 restrains autophagy to limit growth of early stage non-small cell lung cancer

Non-small cell lung cancer (NSCLC) is the most common cancer worldwide. With overall 5-year survival estimated at <17%, it is critical to identify factors that regulate NSCLC disease prognosis. NSCLC is commonly driven by mutations in KRAS and TP53, with activation of additional kinases such as S...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res
Main Authors: Deneka, Alexander Y., Kopp, Meghan C., Nikonova, Anna S., Gaponova, Anna V., Kiseleva, Anna A., Hensley, Harvey H., Flieder, Douglas B., Serebriiskii, Ilya G., Golemis, Erica A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8277748/
https://ncbi.nlm.nih.gov/pubmed/34006524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-20-3626
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados